Recruiting NA INTERVENTIONAL 2-arm
NCT06630377
GOS and the Management of Hyperuricemia
The Effectiveness of Galactooligosaccharide on the Treatment of Hyperuricemia
Sponsor: Sun Yat-sen University
Conditions
Subjects With Hyperuricemia
Updated 1 time since 2024 Last updated: Oct 4, 2024 Started: Jul 15, 2024 Primary completion: Dec 31, 2024 Completion: Dec 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06630377, this NA trial focuses on Subjects With Hyperuricemia and remains actively recruiting participants. Sponsored by Sun Yat-sen University, it has been updated 1 time since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Sun Yat-sen University
Data source: Sun Yat-sen University
For direct contact, visit the study record on ClinicalTrials.gov .